Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 84

1.

Mesenchymal stem cells enhance survival and bacterial clearance in murine Escherichia coli pneumonia.

Gupta N, Krasnodembskaya A, Kapetanaki M, Mouded M, Tan X, Serikov V, Matthay MA.

Thorax. 2012 Jun;67(6):533-9. doi: 10.1136/thoraxjnl-2011-201176. Epub 2012 Jan 16.

2.

Mesenchymal stem cell therapy in acute lung injury: is it time for a clinical trial?

Mac Sweeney R, McAuley DF.

Thorax. 2012 Jun;67(6):475-6. doi: 10.1136/thoraxjnl-2011-201309. Epub 2012 Apr 13. No abstract available.

PMID:
22504891
3.

Lipocalin 2 is protective against E. coli pneumonia.

Wu H, Santoni-Rugiu E, Ralfkiaer E, Porse BT, Moser C, Høiby N, Borregaard N, Cowland JB.

Respir Res. 2010 Jul 15;11:96. doi: 10.1186/1465-9921-11-96.

4.

Intratracheal transplantation of human umbilical cord blood-derived mesenchymal stem cells attenuates Escherichia coli-induced acute lung injury in mice.

Kim ES, Chang YS, Choi SJ, Kim JK, Yoo HS, Ahn SY, Sung DK, Kim SY, Park YR, Park WS.

Respir Res. 2011 Aug 15;12:108. doi: 10.1186/1465-9921-12-108.

5.

Antibacterial effect of mesenchymal stem cells against Escherichia coli is mediated by secretion of beta- defensin- 2 via toll- like receptor 4 signalling.

Sung DK, Chang YS, Sung SI, Yoo HS, Ahn SY, Park WS.

Cell Microbiol. 2016 Mar;18(3):424-36. doi: 10.1111/cmi.12522. Epub 2015 Oct 27.

6.

Therapeutic Effects of Human Mesenchymal Stem Cell-derived Microvesicles in Severe Pneumonia in Mice.

Monsel A, Zhu YG, Gennai S, Hao Q, Hu S, Rouby JJ, Rosenzwajg M, Matthay MA, Lee JW.

Am J Respir Crit Care Med. 2015 Aug 1;192(3):324-36. doi: 10.1164/rccm.201410-1765OC.

7.

Antibacterial effect of human mesenchymal stem cells is mediated in part from secretion of the antimicrobial peptide LL-37.

Krasnodembskaya A, Song Y, Fang X, Gupta N, Serikov V, Lee JW, Matthay MA.

Stem Cells. 2010 Dec;28(12):2229-38. doi: 10.1002/stem.544.

8.

Human mesenchymal stromal cells decrease the severity of acute lung injury induced by E. coli in the rat.

Devaney J, Horie S, Masterson C, Elliman S, Barry F, O'Brien T, Curley GF, O'Toole D, Laffey JG.

Thorax. 2015 Jul;70(7):625-35. doi: 10.1136/thoraxjnl-2015-206813. Epub 2015 May 18.

PMID:
25986435
9.

Interaction of lipocalin 2, transferrin, and siderophores determines the replicative niche of Klebsiella pneumoniae during pneumonia.

Bachman MA, Lenio S, Schmidt L, Oyler JE, Weiser JN.

MBio. 2012 Nov 20;3(6). pii: e00224-11. doi: 10.1128/mBio.00224-11.

10.

Therapeutic effects of human mesenchymal stem cells in ex vivo human lungs injured with live bacteria.

Lee JW, Krasnodembskaya A, McKenna DH, Song Y, Abbott J, Matthay MA.

Am J Respir Crit Care Med. 2013 Apr 1;187(7):751-60. doi: 10.1164/rccm.201206-0990OC.

11.

Lipocalin 2 is required for pulmonary host defense against Klebsiella infection.

Chan YR, Liu JS, Pociask DA, Zheng M, Mietzner TA, Berger T, Mak TW, Clifton MC, Strong RK, Ray P, Kolls JK.

J Immunol. 2009 Apr 15;182(8):4947-56. doi: 10.4049/jimmunol.0803282.

12.

Cryopreserved, Xeno-Free Human Umbilical Cord Mesenchymal Stromal Cells Reduce Lung Injury Severity and Bacterial Burden in Rodent Escherichia coli-Induced Acute Respiratory Distress Syndrome.

Curley GF, Jerkic M, Dixon S, Hogan G, Masterson C, O'Toole D, Devaney J, Laffey JG.

Crit Care Med. 2017 Feb;45(2):e202-e212. doi: 10.1097/CCM.0000000000002073.

PMID:
27861182
13.

Lipocalin2 protects against airway inflammation and hyperresponsiveness in a murine model of allergic airway disease.

Dittrich AM, Krokowski M, Meyer HA, Quarcoo D, Avagyan A, Ahrens B, Kube SM, Witzenrath M, Loddenkemper C, Cowland JB, Hamelmann E.

Clin Exp Allergy. 2010 Nov;40(11):1689-700. doi: 10.1111/j.1365-2222.2010.03508.x.

PMID:
20412141
14.

Prospectively defined murine mesenchymal stem cells inhibit Klebsiella pneumoniae-induced acute lung injury and improve pneumonia survival.

Hackstein H, Lippitsch A, Krug P, Schevtschenko I, Kranz S, Hecker M, Dietert K, Gruber AD, Bein G, Brendel C, Baal N.

Respir Res. 2015 Oct 6;16:123. doi: 10.1186/s12931-015-0288-1.

15.

Lipocalin 2-deficient mice exhibit increased sensitivity to Escherichia coli infection but not to ischemia-reperfusion injury.

Berger T, Togawa A, Duncan GS, Elia AJ, You-Ten A, Wakeham A, Fong HE, Cheung CC, Mak TW.

Proc Natl Acad Sci U S A. 2006 Feb 7;103(6):1834-9. Epub 2006 Jan 30.

16.

AIEC pathobiont instigates chronic colitis in susceptible hosts by altering microbiota composition.

Chassaing B, Koren O, Carvalho FA, Ley RE, Gewirtz AT.

Gut. 2014 Jul;63(7):1069-80. doi: 10.1136/gutjnl-2013-304909. Epub 2013 Jul 29.

17.

The pathogen-associated iroA gene cluster mediates bacterial evasion of lipocalin 2.

Fischbach MA, Lin H, Zhou L, Yu Y, Abergel RJ, Liu DR, Raymond KN, Wanner BL, Strong RK, Walsh CT, Aderem A, Smith KD.

Proc Natl Acad Sci U S A. 2006 Oct 31;103(44):16502-7. Epub 2006 Oct 23.

18.

Effects of intratracheal mesenchymal stromal cell therapy during recovery and resolution after ventilator-induced lung injury.

Curley GF, Ansari B, Hayes M, Devaney J, Masterson C, Ryan A, Barry F, O'Brien T, Toole DO, Laffey JG.

Anesthesiology. 2013 Apr;118(4):924-32. doi: 10.1097/ALN.0b013e318287ba08.

PMID:
23377221
19.

Differential role of lipocalin 2 during immune complex-mediated acute and chronic inflammation in mice.

Shashidharamurthy R, Machiah D, Aitken JD, Putty K, Srinivasan G, Chassaing B, Parkos CA, Selvaraj P, Vijay-Kumar M.

Arthritis Rheum. 2013 Apr;65(4):1064-73. doi: 10.1002/art.37840.

20.

Lipocalin-2 promotes m1 macrophages polarization in a mouse cardiac ischaemia-reperfusion injury model.

Cheng L, Xing H, Mao X, Li L, Li X, Li Q.

Scand J Immunol. 2015 Jan;81(1):31-8. doi: 10.1111/sji.12245.

Supplemental Content

Support Center